Jang J, Hunto S, Kim J, Lee H, Kim H, Cho J
Int J Mol Sci. 2022; 23(7).
PMID: 35409346
PMC: 8999734.
DOI: 10.3390/ijms23073986.
Schihada H, Ma X, Zabel U, Vischer H, Schulte G, Leurs R
ACS Sens. 2020; 5(6):1734-1742.
PMID: 32397705
PMC: 7325232.
DOI: 10.1021/acssensors.0c00397.
Tiligada E, Ennis M
Br J Pharmacol. 2018; 177(3):469-489.
PMID: 30341770
PMC: 7012941.
DOI: 10.1111/bph.14524.
Page C, Humphrey P
Br J Clin Pharmacol. 2012; 75(5):1213-8.
PMID: 22994263
PMC: 3635591.
DOI: 10.1111/j.1365-2125.2012.04467.x.
Parsons M, Ganellin C
Br J Pharmacol. 2006; 147 Suppl 1:S127-35.
PMID: 16402096
PMC: 1760721.
DOI: 10.1038/sj.bjp.0706440.
JB-9322, a new selective histamine H2-receptor antagonist with potent gastric mucosal protective properties.
Palacios B, Montero M, Sevilla M, Roman L
Br J Pharmacol. 1995; 115(1):57-66.
PMID: 7647984
PMC: 1908764.
DOI: 10.1111/j.1476-5381.1995.tb16319.x.
Ranitidine delays gastric emptying of solids in man.
Scarpignato C, Bertaccini G, Zimbaro G, Vitulo F
Br J Clin Pharmacol. 1982; 13(2):252-3.
PMID: 6277357
PMC: 1401998.
DOI: 10.1111/j.1365-2125.1982.tb01373.x.
H2 receptor antagonists and anaesthesia.
G Williams J
Can Anaesth Soc J. 1983; 30(3 Pt 1):264-9.
PMID: 6152891
DOI: 10.1007/BF03013805.
Effect of a new potent H2-receptor antagonist on meal-stimulated gastric acid secretion and serum gastrin concentration in duodenal ulcer patients.
Brozinsky S, Hogan D, Isenberg J, Richardson C
Dig Dis Sci. 1984; 29(2):129-33.
PMID: 6141898
DOI: 10.1007/BF01317053.
Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.
Brogden R, Carmine A, Heel R, Speight T, Avery G
Drugs. 1982; 24(4):267-303.
PMID: 6128216
DOI: 10.2165/00003495-198224040-00002.
Comparative trial of the effect of ranitidine and cimetidine on gastric secretion in fasting patients at induction of anaesthesia.
Durrant J, Strunin L
Can Anaesth Soc J. 1982; 29(5):446-51.
PMID: 6127150
DOI: 10.1007/BF03009407.
Ranitidine upon meal-induced gastric secretion: oral pharmacokinetics and plasma concentration effect relationships.
Mignon M, Chau N, Sauvage M, Leguy F, Bonfils S
Br J Clin Pharmacol. 1982; 14(2):187-93.
PMID: 6125203
PMC: 1427757.
DOI: 10.1111/j.1365-2125.1982.tb01960.x.
Cholinergic-like effects of the new histamine H2-receptor antagonist ranitidine.
Bertaccini G, Coruzzi G
Agents Actions. 1982; 12(1-2):168-71.
PMID: 6123238
DOI: 10.1007/BF01965134.
Inhibition by the tetramine disulphide, benextramine, of cardiac chronotropic histamine H2-receptor-mediated effects.
Belleau B, Benfey B, Benfey T, Melchiorre C
Br J Pharmacol. 1982; 75(4):573-8.
PMID: 6121599
PMC: 2071524.
DOI: 10.1111/j.1476-5381.1982.tb09176.x.
Effect of some new Histamine H2-receptor antagonists on the guinea-pig papillary muscle.
Bertaccini G, Coruzzi G
Naunyn Schmiedebergs Arch Pharmacol. 1981; 317(3):225-7.
PMID: 6119622
DOI: 10.1007/BF00503821.
Pharmacokinetics of the H2- receptor antagonist ranitidine in man.
McNeil J, Mihaly G, Anderson A, Marshall A, Smallwood R, Louis W
Br J Clin Pharmacol. 1981; 12(3):411-5.
PMID: 6117305
PMC: 1401817.
DOI: 10.1111/j.1365-2125.1981.tb01236.x.
Mesenteric vascular reactivity to histamine receptor agonists and antagonists.
Walus K, Fondacaro J, Jacobson E
Dig Dis Sci. 1981; 26(5):438-43.
PMID: 6113921
DOI: 10.1007/BF01313587.
H2-receptor antagonists protect against aspirin-induced gastric lesions in the rat.
Bunce K, Daly M, Humphray J, Stables R
Agents Actions. 1981; 11(1-2):167-70.
PMID: 6113744
DOI: 10.1007/BF01991491.
Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine.
Daly M, Humphray J, Stables R
Br J Pharmacol. 1981; 72(1):49-54.
PMID: 6112034
PMC: 2071551.
DOI: 10.1111/j.1476-5381.1981.tb09103.x.
Binding of [3H]cimetidine to rat brain tissue.
Smith I, Cleverley M, Ganellin C, Metters K
Agents Actions. 1980; 10(5):422-6.
PMID: 6111196
DOI: 10.1007/BF01968040.
